Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analgesic use in cluster headache

R M Gallagher1, L Mueller, C A Ciervo

  • 1University Headache Center, University of Medicine & Dentistry of New Jersey, Moorestown 08057, USA.

Headache
|February 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of repeated low-dose LSD on neuropsychological functioning in adults with ADHD: a randomized placebo-controlled study.

Psychopharmacology·2026
Same author

The role of body composition and visceral fat in osteoporosis subtype differentiation: Insights from bioelectrical impedance analysis.

Journal of orthopaedics·2025
Same author

Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.

European journal of immunology·2025
Same author

Low androgen signaling rescues genome integrity with innate immune response by reducing fertility in humans.

Cell death & disease·2024
Same author

Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212).

ESMO open·2023
Same author

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same journal

Weight loss with atogepant in the long-term treatment of migraine: An interim analysis of a safety endpoint from a phase 3, multicenter, open-label, 156-week extension study.

Headache·2026
Same journal

American Headache Society 68th Annual Scientific Meeting June 4-7, 2026, Orlando, Florida.

Headache·2026
Same journal

In Memoriam-Doctor J. Keith Campbell.

Headache·2026
Same journal

Hypothalamus as a conductor of the migraine prodrome: A narrative review.

Headache·2026
Same journal

New academic year in Headache.

Headache·2026
Same journal

Essential readings in headache medicine: Top 10 educational articles from 2025.

Headache·2026
See all related articles

Cluster headache patients often prefer analgesics despite minimal relief, while many decline effective oxygen therapy. This suggests non-pain related factors influence treatment choices for cluster headaches.

Area of Science:

  • Neurology
  • Pain Medicine

Background:

  • Cluster headache presents as severe, brief, and frequent attacks.
  • Standard symptomatic analgesics are often ineffective due to attack intensity and duration.
  • Inhalation oxygen is recognized as effective but can be cumbersome.

Purpose of the Study:

  • To evaluate the practical effectiveness and usage patterns of analgesics and oxygen in cluster headache patients.
  • To understand patient preferences and reasons for continued or declined use of these treatments.

Main Methods:

  • A review of 60 cluster headache patients was conducted.
  • Data collected on the use of oral analgesics and inhalation oxygen for breakthrough headaches.
  • Patient adherence and reported relief were assessed after establishing prophylactic treatment.

Related Experiment Videos

Main Results:

  • 65% of patients continued using analgesics, reporting minimal relief.
  • Only 31% of patients continued using oxygen, despite most reporting significant relief.
  • Patients' preference for analgesics was not solely based on pain relief effectiveness.

Conclusions:

  • Cluster headache patients may prioritize factors beyond pain relief when choosing treatments.
  • Barriers to oxygen use exist, independent of its therapeutic effectiveness.
  • Further research is needed to explore non-efficacy-related reasons for treatment adherence in cluster headache.